We recently published a list of 10 Stocks Market Experts are Talking About These Days. In this article, we are going to take ...

Pfizer PFE underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.

Pfizer has exited Haleon through four block trades, the most recent of which was its sale of a 7.7% stake in January at a 2.75% discount. GSK sold its last shares in the company last year. Also on ...

Pfizer Inc. is looking to sell its remaining 7.3% stake in Haleon Plc, culminating a multi-year separation from the maker of Sensodyne toothpaste.Most Read from BloombergICE Eyes Massive California ...

Pfizer Inc on Tuesday said it will sell its entire residual stake in Haleon PLC, offloading approximately 662 million shares in the consumer health firm through a secondary offering and a share ...

Haleon--which owns brands such as Sensodyne toothpaste, Aquafresh mouthwash and over-the-counter medicines Panadol and Advil--was formed in July 2019 through the merger of GSK and Pfizer's ...

Many Pokémon Go players want an easier way to explore the game world without moving too much. Spoofing is one of ...

Xponance Inc. grew its holdings in Pfizer Inc. (NYSE:PFE - Free Report) by 4.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The ...

JPMorgan notes that Pfizer’s (PFE) decision on a potential move into Phase 3 for danuglipron, an oral GLP-1 drug, is expected in the coming ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from the tariff wars, Maggie Fick of ...